Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar

Hdl Handle:
http://hdl.handle.net/10144/618663
Title:
Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar
Authors:
Thiha, N; Chinnakali, P; Harries, AD; Shwe, M; Balathandan, TP; Thein Than Tun, S; Das, M; Tin, HH; Yi, Y; Babin, FX; Lwin, TT; Clevenbergh, PA
Journal:
PloS One
Abstract:
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced with tenofovir (TDF) for first-line treatment. In this context, the Integrated HIV Care Program, Myanmar, evaluated patients for ART failure using HIV RNA viral load (VL) before making the change. We aimed to determine prevalence and determinants of ART failure in those on first-line treatment.
Publisher:
Public Library of Science
Issue Date:
9-Aug-2016
URI:
http://hdl.handle.net/10144/618663
DOI:
10.1371/journal.pone.0160616
PubMed ID:
27505228
Language:
en
ISSN:
1932-6203
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorThiha, Nen
dc.contributor.authorChinnakali, Pen
dc.contributor.authorHarries, ADen
dc.contributor.authorShwe, Men
dc.contributor.authorBalathandan, TPen
dc.contributor.authorThein Than Tun, Sen
dc.contributor.authorDas, Men
dc.contributor.authorTin, HHen
dc.contributor.authorYi, Yen
dc.contributor.authorBabin, FXen
dc.contributor.authorLwin, TTen
dc.contributor.authorClevenbergh, PAen
dc.date.accessioned2016-09-15T15:31:44Z-
dc.date.available2016-09-15T15:31:44Z-
dc.date.issued2016-08-09-
dc.identifier.citationIs There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar. 2016, 11 (8):e0160616 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid27505228-
dc.identifier.doi10.1371/journal.pone.0160616-
dc.identifier.urihttp://hdl.handle.net/10144/618663-
dc.description.abstractWHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced with tenofovir (TDF) for first-line treatment. In this context, the Integrated HIV Care Program, Myanmar, evaluated patients for ART failure using HIV RNA viral load (VL) before making the change. We aimed to determine prevalence and determinants of ART failure in those on first-line treatment.en
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleIs There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmaren
dc.identifier.journalPloS Oneen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.